IRIS
ORDITURA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.570
NA - Nord America 5.948
AS - Asia 4.906
SA - Sud America 813
AF - Africa 86
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.345
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.860
US - Stati Uniti d'America 5.805
SG - Singapore 1.600
IE - Irlanda 1.380
CN - Cina 1.069
HK - Hong Kong 795
IT - Italia 718
BR - Brasile 680
UA - Ucraina 635
VN - Vietnam 601
GB - Regno Unito 504
DE - Germania 495
FR - Francia 347
KR - Corea 333
FI - Finlandia 188
SE - Svezia 148
IN - India 123
GR - Grecia 121
TR - Turchia 106
CA - Canada 89
JP - Giappone 82
AR - Argentina 44
PL - Polonia 36
BD - Bangladesh 34
MX - Messico 34
ID - Indonesia 33
NL - Olanda 30
IQ - Iraq 27
AT - Austria 26
EC - Ecuador 23
ZA - Sudafrica 19
BE - Belgio 16
MA - Marocco 16
VE - Venezuela 15
CO - Colombia 14
ES - Italia 14
SC - Seychelles 13
CL - Cile 12
CZ - Repubblica Ceca 11
PK - Pakistan 10
AL - Albania 9
TN - Tunisia 9
NP - Nepal 8
PE - Perù 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
NZ - Nuova Zelanda 7
PH - Filippine 7
PY - Paraguay 7
AU - Australia 6
EU - Europa 6
IR - Iran 6
LT - Lituania 6
MY - Malesia 6
TH - Thailandia 6
UZ - Uzbekistan 6
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
JO - Giordania 5
HN - Honduras 4
JM - Giamaica 4
LB - Libano 4
SN - Senegal 4
UY - Uruguay 4
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
Totale 24.336
Salva come PNG Salva come JPEG
Città #
Moscow 2.854
Dublin 1.369
Jacksonville 935
Hong Kong 787
San Jose 732
Santa Clara 726
Singapore 671
Chandler 643
Seoul 310
Ashburn 200
Ho Chi Minh City 189
Princeton 188
Medford 171
New York 144
Hanoi 137
Caserta 129
Bremen 122
Beijing 120
Hefei 119
Roxbury 118
Ann Arbor 107
Boardman 103
Naples 95
San Mateo 94
Bengaluru 87
Munich 85
Wilmington 75
São Paulo 60
Woodbridge 60
Los Angeles 54
Dallas 53
The Dalles 53
Elora 52
Nanjing 49
Des Moines 46
Dong Ket 36
Napoli 36
Cambridge 34
Nuremberg 34
Haiphong 33
Jinan 32
Kraków 29
Milan 27
Da Nang 26
Rio de Janeiro 23
Helsinki 21
Houston 21
Mountain View 20
Turku 18
Changsha 17
Tianjin 17
Rome 16
Amsterdam 15
Brussels 15
Norwalk 15
Shanghai 15
Vienna 15
Aiello Del Sabato 14
Curitiba 14
Nanchang 14
Shenyang 14
Belo Horizonte 13
Hangzhou 13
Biên Hòa 12
Guangzhou 12
Porto Alegre 12
Tokyo 12
Brasília 11
Chennai 11
Council Bluffs 11
Orem 11
Ottawa 11
Toronto 11
Zhengzhou 11
Atlanta 10
Auburn Hills 10
Aversa 10
Brno 10
Campinas 10
Guarulhos 10
Hải Dương 10
Johannesburg 10
Taizhou 10
Thái Bình 10
Thái Nguyên 10
Baghdad 9
Frankfurt am Main 9
Istanbul 9
Jakarta 9
Mexico City 9
Columbus 8
Dhaka 8
Düsseldorf 8
Guayaquil 8
Brooklyn 7
Bắc Ninh 7
Caracas 7
Chicago 7
Ercolano 7
Falkenstein 7
Totale 12.688
Salva come PNG Salva come JPEG
Nome #
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 214
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 208
ONCOLOGIA MEDICA 206
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 201
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 194
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 182
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 181
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 179
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 177
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 177
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 177
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 173
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 172
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 171
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 171
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 170
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 169
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 168
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 168
Clinical management of advanced gastric cancer: Role of new molecular drugs. 166
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 164
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 163
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 162
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 161
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 160
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 160
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 159
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series 158
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 158
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 157
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 155
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 154
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 154
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 151
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 150
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 150
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 150
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 148
Treatment of gastric cancer. 147
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 144
Adult Wilms' tumor: a case report 144
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 144
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 144
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review 142
Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review 141
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 141
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 141
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 140
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 138
Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery 138
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 137
Farmacogenomica e cancro colorettale 137
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 137
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 137
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 136
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 136
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 136
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 135
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 135
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review 134
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 132
Adjuvant chemotherapy of gastric cancer: which regimen? 131
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 131
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 130
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 130
Cardiotossicità da antracicline: attualità e prospettive 130
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 129
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 128
TRASTUZUMAB RESISTANCE IN BREAST CANCER 128
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 127
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 127
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 127
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 126
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 126
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 125
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 125
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 125
Il linfoma primitivo della parotide: una localizzazione infrequente 125
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 125
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 125
Integrated therapy in localized gastric cancer: targeted and tailored approach. 124
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 123
Targeting EGFR in Pancreatic Cancer Treatment. 123
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 123
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 122
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 121
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 121
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy 121
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 120
Chemoradiotherapy as adjuvant treatment of gastric cancer 120
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 120
Ventricular repolarization time indexes following anthracycline treatment 120
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation 119
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 119
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 117
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 117
Pancreatic neuroendocrine tumors: Nosography, management and treatment 117
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 116
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 116
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial 116
Totale 14.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021375 0 0 0 0 0 0 0 0 0 165 144 66
2021/20221.150 99 3 17 19 407 6 19 37 41 53 114 335
2022/20232.666 319 45 37 206 304 205 15 158 1.281 11 44 41
2023/2024993 84 31 48 85 347 127 9 21 8 18 64 151
2024/20253.006 22 92 40 76 476 383 396 275 414 346 233 253
2025/202612.892 484 606 636 678 1.036 7.367 582 766 454 283 0 0
Totale 24.889